Nawaz Haq, Fan Chen Yi, Kloke John, Khalid Asif, McGrath Kevin, Landsittel Douglas, Papachristou Georgios I
Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center. Pittsburgh, PA, USA.
JOP. 2013 Sep 10;14(5):484-97. doi: 10.6092/1590-8577/1512.
The optimal approach to pre-operative imaging assessment of pancreatic cancer is unknown.
The aim of this meta-analysis was to assess accuracy and performance characteristics of EUS in determining nodal staging, vascular invasion, and prediction of resectability of pancreatic cancer. A secondary aim was to perform head to head comparison of performance characteristics between EUS and CT for nodal staging, vascular invasion and resectability.
Data from EUS studies were pooled according to bivariate generalized random effects model. Pooled estimates for CT were obtained from studies which performed head to head comparison between EUS and CT.
Patients with pancreatic cancer undergoing pre-operative imaging assessment.
EUS.
Pooled sensitivity, specificity, positive and negative predictive values of EUS for nodal staging, vascular invasion and resectability.
Forty-nine studies were considered of which 29 met inclusion criteria with a total of 1,330 patients. Pooled summary estimates for EUS-nodal staging were 69% for sensitivity and 81% for specificity. For vascular invasion, sensitivity was 85% and specificity was 91%. The sensitivity and specificity for resectability was 90% and 86%, respectively. CT scan showed lower sensitivity than EUS for nodal staging (24% vs. 58%) and vascular invasion (58% vs. 86%); however, the specificities for nodal staging (88% vs. 85%) and vascular invasion (95% vs. 93%) were comparable in studies where both imaging techniques were performed. The sensitivity and specificity of CT in determining resectability (90% and 69%) was similar to that of EUS (87% and 89%).
EUS is an accurate pre-operative tool in the assessment of nodal staging, vascular invasion and resectability in patients with pancreatic cancer.
胰腺癌术前影像评估的最佳方法尚不清楚。
本荟萃分析的目的是评估超声内镜(EUS)在确定胰腺癌淋巴结分期、血管侵犯及可切除性预测方面的准确性和性能特征。次要目的是对EUS和CT在淋巴结分期、血管侵犯及可切除性方面的性能特征进行直接比较。
根据双变量广义随机效应模型汇总EUS研究的数据。CT的汇总估计值来自对EUS和CT进行直接比较的研究。
接受术前影像评估的胰腺癌患者。
EUS。
EUS在淋巴结分期、血管侵犯及可切除性方面的汇总敏感性、特异性、阳性和阴性预测值。
共纳入49项研究,其中29项符合纳入标准,总计1330例患者。EUS淋巴结分期的汇总敏感性为69%,特异性为81%。血管侵犯方面,敏感性为85%,特异性为91%。可切除性的敏感性和特异性分别为90%和86%。CT扫描在淋巴结分期(24%对58%)和血管侵犯(58%对86%)方面的敏感性低于EUS;然而,在同时进行两种成像技术的研究中,淋巴结分期(88%对85%)和血管侵犯(95%对93%)的特异性相当。CT在确定可切除性方面的敏感性和特异性(90%和69%)与EUS(87%和89%)相似。
EUS是评估胰腺癌患者淋巴结分期、血管侵犯及可切除性的一种准确的术前工具。